Displaying items by tag: Perrigo Co plc

ALLEGAN — Fighting off a hostile takeover bid cost Perrigo Co. plc $100 million last year, driving up administrative expenses sharply for the producer of over-the-counter medications.

Published in Economic Development

Perrigo Co. plc (NYSE: PRGO) lost money during the fourth quarter of 2015, the result of problems in its Branded Consumer Healthcare division.

Published in Breaking News

Two months after fending off a hostile takeover bid, Perrigo Co. plc raised its earnings expectations for 2016, a byproduct of projected growth and a cost-cutting plan the company launched last fall.

Published in Health Care
Monday, 11 January 2016 11:25

Perrigo raises earnings guidance for 2016

The company now expects full-year earnings of $9.50 to $10.10 per diluted share, up from the guidance issued in October 2015 of $9.30 per diluted share.

Published in Breaking News
Page 7 of 7